Vancomycin removal by plasmapheresis

Pharmacology and Toxicology

Volumn 81, Issue 5, 1997, Pages 245-246

  Osman, Buari A ^a   Lew, Susie Q ^a,b  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

ACUTE KIDNEY FAILURE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CASE REPORT; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG HALF LIFE; HEMODIALYSIS; HUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

BACTERIA (MICROORGANISMS); PURPURA; STAPHYLOCOCCUS;

EID: 0030723210     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1997.tb00055.x     Document Type: Article

References (16)

1. Ayus, J. C., J. F. Eneas, T. G. Tong, N. L. Benowitz, P. Y. Schoenfield, X. L. Hadley, C. E. Becker & M. H. Humphrey: Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis. Clin. Nephrol. 1979, 11, 129-132.
2. Bozkurt, F., P. Schollmeyer & E. Keller: Kinetics of ceftazidime during plasmapheresis. Eur. J. Clin. Pharmcol. 1987, 33, 197-201.
3. Bakken, J. S., S. J. Cavalieri, D. Gangeness, T. Kubat & R. J. Pollack: Influence of therapeutic plasmapheresis on elimination of ceftriaxone. Antimicrob. Agents Chemotherap 1993, 37, 1171-1173.
4. Bennett, W. M., G.R. Aronoff, T. A. Golper & G. Morrison (Eds.): Drug prescribing in renal failure - Dosing guidelines for adults. 3rd ed. American College of Physician dosing guidelines. American College of Physician, Philadelphia, 1994, p. 27.
5. Fauvelle, F., O. Lortholary, M. Tod, L. Guillevin, M. Louchahi, A. Leon & O. Petitjean: Pharmacokinetics of ceftriaxone during plasma exchange in polyarteritis nodosa patients. Antimicrob. Agents Chemother. 1994, 38, 1519-1522.
6. Fauvelle, F., P. Nicolas, A. Leon, M. Tod, G. Perret, O. Petitjean & L. Guillevan: Diclofenac, paracetamol and vidarabine removal during plasma exchange in polyarteritis nodosa patients. Biopharm. Drug Dispos. 1991, 12, 411-424.
7. Geraci, J. E.: Vancomycin. Mayo Clinic Proceedings 1977, 52, 631-634.
8. Krogstad, D. J., R. C. Moellering Jr. & D. J. Greenblatt: Single-dose kinetics of intravenous vancomycin. J Clin. Pharmacol. 1980, 20, 197-201.
9. LeRoux, P., M. A. Howard & H. R. Winn: Vancomycin pharmacokinetics in hydrocephalic shunt prophylaxis and relationship to ventricular volume. Surg. Neurol. 1990, 34, 366-372.
10. Magerra, B. E., J. C. Arroyo, S. J. Rosansky & B. Postic: Vancomycin pharmacokinetics in patients with peritonitis on peritoneal dialysis. Antimicrob. Agents Chemotherap. 1983, 23, 710-714.
11. Matzke, G. R., M. D. O'Connell, A. J. Collins & P. R. Keshaviah: Disposition of vancomycin during hemofiltration. Clin. Pharmacol. Therap. 1986, 40, 425-430.
12. Moellering, R. C., D. J. Krogstad & D. J. Greenblatt: Vancomycin therapy in patients with impaired renal function: A normogram for dosage. Ann. Intern. Med. 1981, 94, 343-346.
13. Rawer, P. & K. E. Deim: Elimination of vancomycin during hemo-filtration. Eur. J. Clin. Microb. Dis. 1989, 8, 529-531.
14. Rotschafer, J. C., K. Crossley, D. E. Zaske, K. Mead, R. J. Sawchuk & L. D. Solem: Pharmacokinetics of vancomycin: Observations in 28 patients and dosage recommendations. Antimicrob. Agents Chemotherap. 1982, 22, 391-394.
15. Sketris, I. S., W. A. Parker, & V. J. Jones: Plasmapheresis: its effect on toxic agents and drugs. Plasma Therap. Transfus. Technol. 1984, 5, 305-317.
16. Tan, C. C., H. S. Lee, T. Y. Ti & E. J. Lee: Pharmacokinetics of intravenous vancomycin in patients with end-stage renal disease. Ther. Drug Monit. 1990, 12, 29-34.